Activity ID
9754Expires
August 2, 2025Format Type
EnduringCME Credit
0.75Fee
$113CME Provider: Louisiana Medical Mutual Insurance Company (LAMMICO)
Description of CME Course
According to the CDC, atrial fibrillation (AF) is the most common type of heart arrhythmia. It is estimated that 3 – 6 million people in the US have AF and this number is expected to increase. The most common consequence of AF is thromboembolism (TE) leading to stroke. To prevent stroke in patients with AF, anticoagulation therapy is recommended but there are now many choices. Part 2 of this 2-part series discusses the risks of anticoagulation treatment and reversal therapies.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Relate the risk assessment protocols for stroke due to AF and type of anticoagulation therapy needed. Utilize the reversal therapies for anticoagulants when needed. Discuss the risks of anticoagulant treatment and avoid common medical errors made in their prescription.
Keywords
Anticoagulation, NOACs, atrial fibrillation
Competencies
Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement
CME Credit Type
AMA PRA Category 1 Credit
